Pasithea Therapeutics Corp.
KTTA
$0.58
$0.00-0.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 71.62% | -232.88% | 18.27% | -4.29% | -12.13% |
| Total Depreciation and Amortization | 0.00% | -13.27% | 12.31% | -0.43% | 0.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -130.06% | 4,182.39% | 65.65% | 127.68% | -75.30% |
| Change in Net Operating Assets | -504.04% | 22.28% | 62.35% | -220.23% | -30.54% |
| Cash from Operations | 11.30% | -86.74% | 25.30% | -26.61% | -25.08% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -100.00% | 253.92% | 551,100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 66.15% | -2.29% | -- | -- |
| Cash from Financing | -100.00% | 48,697.42% | -102.02% | 289.27% | 6,347.03% |
| Foreign Exchange rate Adjustments | 5,520.00% | -96.06% | 126.79% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -109.32% | 1,804.90% | -259.59% | 218.61% | 35.14% |